Status:
COMPLETED
Community Reinforcement Approach and Family Training for Substance Use in Early Psychosis Intervention
Lead Sponsor:
Centre for Addiction and Mental Health
Collaborating Sponsors:
Mclean Hospital
Conditions:
Psychosis
Schizophrenia and Related Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this pilot feasibility and proof of concept study is to evaluate whether Community Reinforcement and Family Training (CRAFT) as adapted for group delivery in an early psychosis interventio...
Detailed Description
Substance use has a major impact on the prevalence and course of early psychosis in young people. Substance use disorders occur in over 40% of people with schizophrenia spectrum disorders. There is in...
Eligibility Criteria
Inclusion
- Concerned significant other (CSO)
- Adult (at least 18 years) family member of an identified patient (IP) enrolled in SCEI treatment. The IP should be aged 16-29 years with clinician diagnosis of early psychosis (schizophrenia, schizoaffective disorder, schizophreniform disorder, bipolar I disorder, major depressive disorder with psychotic features, substance-induced psychotic disorder, or unspecified schizophrenia spectrum and other psychotic disorder). The IP does NOT need to be enrolled in the study in order for the CSO to participate. Up to 2 CSOs associated with the same IP may participate.
- Has completed the program's introductory psychoeducation group
- Concerned about substance use in the IP enrolled in the early psychosis intervention program
- Identified patient
- Enrolled in the early psychosis intervention program, aged 16-29 years with clinician diagnosis of early psychosis (schizophrenia, schizoaffective disorder, schizophreniform disorder, bipolar I disorder, major depressive disorder with psychotic features, substance-induced psychotic disorder, or unspecified schizophrenia spectrum and other psychotic disorder)
- Not currently receiving specialized substance use treatment (i.e. by a clinician other than their NAVIGATE clinicians)
Exclusion
- Concerned significant other
- Inability to provide informed consent
- Inability to communicate in basic oral and written English.
- There are already 2 CSOs associated with a given IP that are participating in the CRAFT-EPI study.
- Lack of a device for videoconferencing and a secure Wi-Fi connection
- Unwilling to turn camera on for weekly group sessions (except in the case of a poor Wi-Fi connection, or other similar circumstances)
- Identified patient
- Does not have a CSO that is enrolled in the CRAFT-EPI study
- Inability to provide informed consent
- Inability to communicate in basic oral and written English
Key Trial Info
Start Date :
February 8 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 28 2022
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT05300633
Start Date
February 8 2022
End Date
September 28 2022
Last Update
September 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Addiction and Mental Health
Toronto, Ontario, Canada, M6J1H1